Non-Insulin Pharmacologic Management of Diabetes
- Review non-insulin glycemic lowering medications for patients with type 2 diabetes, specifically GLP-1 agonists and SGLT-2 inhibitors
- Understand their mechanisms, adverse effects, and dosing
- Address the most recent data to guide the use of GLP-1 agonists and SGLT-2 inhibitors in distinct populations
- Apply understanding of medication administration to case examples to enhance clinical skills
Recommended CitationFlink, MD, Lilli, "Non-Insulin Pharmacologic Management of Diabetes" (2021). Department of Family & Community Medicine Presentations and Grand Rounds. Paper 463.